Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors

by on Thursday, October 20th, 2011 | No Comments

Conditions:   Neuroendocrine Tumors;   Liver Metastases
Intervention:   Drug: 177Lu-DOTA-TATE
Sponsor:   Lund University Hospital
Recruiting – verified October 2011

Read more: A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors



Tags: , , , , , , , , , , , , ,
Posted in Cancer Clinical Trials

Comments are closed.